Browsing Tag
Federal Trade Commission
25 posts
IonQ closes $1.8bn SkyWater deal after FTC splits 1-1 on quantum conditions
IonQ closed the $1.8bn SkyWater buy after a 1-1 FTC split, gaining a Pentagon-accredited US foundry ahead of an Aug 5 earnings call that now matters more.
Qorvo (NASDAQ: QRVO) signs worldwide distribution pact with Rochester Electronics on defense RF
Qorvo (NASDAQ: QRVO) signs Rochester Electronics deal for long-term RF supply, deepening its defense positioning before the Skyworks merger closes in 2027.
Could UniFirst’s Q3 results affect the Cintas acquisition spread for UNF stock?
UniFirst’s Q3 revenue rose 3.9%, but merger and ERP costs hit margins as UNF investors watch the Cintas deal and FTC review.
Kroger (NYSE: KR) to reboot consolidation strategy with $1.65bn acquisition of Giant Eagle
Kroger (KR) to acquire Giant Eagle for $1.65B, adding 197 stores and $9B in sales across five states. First major deal since the Albertsons collapse.
US Supreme Court expands presidential firing power but shields Federal Reserve independence
The Supreme Court put most independent regulators under presidential control but spared the Federal Reserve, creating two systems of agency independence.
Why Amazon’s Australian Prime Video lawsuit could matter far more than its $2.25m settlement
Amazon faces regulatory pressure in the U.S. and Australia over identity theft records and Prime Video ads. Read what it means for AMZN investors in 2026.
Why Trump’s Supreme Court victory could reshape the federal government
Trump’s Supreme Court win over FTC removals could reshape independent agencies, presidential power, regulation and federal oversight.
The chatbot era is ending. Here is where Spyne sees the next dealership AI battle
Spyne’s Q2 2026 analysis argues that affordability, constrained used-vehicle supply and fragmented dealer data are pushing artificial intelligence from isolated tools into connected retail execution. The larger implication is that disciplined workflows, rather than AI novelty, will determine whether dealerships gain margin or merely add another software bill.
The factory is 60% empty. That may be exactly why Aurobindo Pharma (NSE: AUROPHARMA) wants it
Read how Aurobindo Pharma plans to turn Lannett’s underused US factory, ADHD portfolio and CDMO platform into its next growth engine as policy shifts.
Aurobindo Pharma clears FTC hurdle for $250m Lannett acquisition
Aurobindo Pharma clears the FTC hurdle for its $250 million Lannett deal. Explore divestitures, US expansion, integration risks and stock outlook.